XML 48 R16.htm IDEA: XBRL DOCUMENT v3.19.3
Stockholders’ Equity
9 Months Ended
Sep. 30, 2019
Equity [Abstract]  
Stockholders’ Equity

11.

Stockholders’ Equity

 

The following tables present changes in stockholders’ equity for the nine months ended September 30, 2019 and 2018 (in thousands, except share data):

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Accumulated

Other

 

 

 

 

 

 

Total

 

 

 

Common

 

 

Paid-In

 

 

Comprehensive

 

 

Accumulated

 

 

Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

(Loss) Income

 

 

Deficit

 

 

Equity

 

Balance at December 31, 2018

 

 

45,224,480

 

 

$

5

 

 

$

478,968

 

 

$

(28

)

 

$

(201,025

)

 

$

277,920

 

Retroactive adjustment to beginning accumulated deficit for

   adoption of ASC 842

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(320

)

 

 

(320

)

Issuance of common stock through at-the-market offerings, net

   of issuance costs of $120

 

 

223,818

 

 

 

-

 

 

 

3,639

 

 

 

-

 

 

 

-

 

 

 

3,639

 

Exercise of stock options

 

 

30,800

 

 

 

-

 

 

 

360

 

 

 

-

 

 

 

-

 

 

 

360

 

Equity-based compensation

 

 

-

 

 

 

-

 

 

 

4,592

 

 

 

-

 

 

 

-

 

 

 

4,592

 

Other comprehensive gain

 

 

-

 

 

 

-

 

 

 

-

 

 

 

87

 

 

 

-

 

 

 

87

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(21,940

)

 

 

(21,940

)

Balance at March 31, 2019

 

 

45,479,098

 

 

 

5

 

 

 

487,559

 

 

 

59

 

 

 

(223,285

)

 

 

264,338

 

Issuance of common stock through at-the-market offerings, net

   of issuance costs of $3

 

 

1,986,579

 

 

 

-

 

 

 

31,413

 

 

 

-

 

 

 

-

 

 

 

31,413

 

Exercise of stock options

 

 

203,072

 

 

 

-

 

 

 

1,664

 

 

 

-

 

 

 

-

 

 

 

1,664

 

Issuance of shares under employee stock purchase plan

 

 

45,826

 

 

 

-

 

 

 

534

 

 

 

-

 

 

 

-

 

 

 

534

 

Equity-based compensation

 

 

-

 

 

 

-

 

 

 

4,404

 

 

 

-

 

 

 

-

 

 

 

4,404

 

Other comprehensive gain

 

 

-

 

 

 

-

 

 

 

-

 

 

 

196

 

 

 

-

 

 

 

196

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(25,683

)

 

 

(25,683

)

Balance at June 30, 2019

 

 

47,714,575

 

 

 

5

 

 

 

525,574

 

 

 

255

 

 

 

(248,968

)

 

 

276,866

 

Issuance of common stock through at-the-market offerings, net

   of issuance costs of $199

 

 

1,141,411

 

 

 

-

 

 

 

19,068

 

 

 

-

 

 

 

-

 

 

 

19,068

 

Exercise of stock options

 

 

21,311

 

 

 

-

 

 

 

192

 

 

 

-

 

 

 

-

 

 

 

192

 

Equity-based compensation

 

 

-

 

 

 

-

 

 

 

3,079

 

 

 

-

 

 

 

-

 

 

 

3,079

 

Other comprehensive gain

 

 

-

 

 

 

-

 

 

 

-

 

 

 

81

 

 

 

-

 

 

 

81

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(23,634

)

 

 

(23,634

)

Balance at September 30, 2019

 

 

48,877,297

 

 

$

5

 

 

$

547,913

 

 

$

336

 

 

$

(272,602

)

 

$

275,652

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Additional

 

 

Accumulated

Other

 

 

 

 

 

 

Total

 

 

 

Common

 

 

Paid-In

 

 

Comprehensive

 

 

Accumulated

 

 

Stockholders’

 

 

 

Shares

 

 

Amount

 

 

Capital

 

 

(Loss) Income

 

 

Deficit

 

 

Equity

 

Balance at December 31, 2017

 

 

42,384,623

 

 

$

4

 

 

$

421,706

 

 

$

-

 

 

$

(121,113

)

 

$

300,597

 

Retroactive adjustment to beginning accumulated deficit for

   adoption of ASU 2014-09

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

5,431

 

 

 

5,431

 

Exercise of stock options

 

 

709,321

 

 

 

-

 

 

 

6,720

 

 

 

-

 

 

 

-

 

 

 

6,720

 

Cancellation of restricted stock

 

 

(2,022

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Equity-based compensation

 

 

-

 

 

 

-

 

 

 

4,107

 

 

 

-

 

 

 

-

 

 

 

4,107

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(21,356

)

 

 

(21,356

)

Balance at March 31, 2018

 

 

43,091,922

 

 

 

4

 

 

 

432,533

 

 

 

-

 

 

 

(137,038

)

 

 

295,499

 

Exercise of stock options

 

 

68,163

 

 

 

-

 

 

 

557

 

 

 

-

 

 

 

-

 

 

 

557

 

Issuance of shares under employee stock purchase plan

 

 

32,707

 

 

 

-

 

 

 

598

 

 

 

-

 

 

 

-

 

 

 

598

 

Cancellation of restricted stock

 

 

(4,780

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Equity-based compensation

 

 

-

 

 

 

-

 

 

 

4,901

 

 

 

-

 

 

 

-

 

 

 

4,901

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(22,219

)

 

 

(22,219

)

Balance at June 30, 2018

 

 

43,188,012

 

 

 

4

 

 

 

438,589

 

 

 

-

 

 

 

(159,257

)

 

 

279,336

 

Exercise of stock options

 

 

204,658

 

 

 

-

 

 

 

2,180

 

 

 

-

 

 

 

-

 

 

 

2,180

 

Cancellation of restricted stock

 

 

(23,347

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Equity-based compensation

 

 

-

 

 

 

-

 

 

 

4,456

 

 

 

-

 

 

 

-

 

 

 

4,456

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(22,702

)

 

 

(22,702

)

Balance at September 30, 2018

 

 

43,369,323

 

 

$

4

 

 

$

445,225

 

 

$

-

 

 

$

(181,959

)

 

$

263,270

 

 

At-the-Market Offering Programs

On October 12, 2018, the Company filed a Registration Statement on Form S-3 (the “2018 Shelf”) with the SEC in relation to the registration of common stock, preferred stock, warrants and units of any combination thereof for the purposes of selling, from time to time, its common stock, convertible securities or other equity securities in one or more offerings. The Company also simultaneously entered into an Open Market Sale Agreement (the “2018 Sales Agreement”) with Jefferies LLC, (the “Sales Agent”), to provide for the offering, issuance and sale by the Company of up to an aggregate amount of $100.0 million of its common stock from time to time in “at-the-market” offerings under the 2018 Shelf and subject to the limitations thereof.  The Company will pay to the Sales Agent cash commissions of 3.0 percent of the gross proceeds of sales of common stock under the 2018 Sales Agreement. In November 2018, the Company issued 1,659,300 shares of its common stock at $18.00 per share in accordance with the 2018 Sales Agreement for net proceeds of $28.5 million, after payment of cash commissions to the Sales Agent and approximately $0.4 million related to legal, accounting and other fees in connection with the sales. During the nine months ended September 30, 2019, the Company issued an additional 3,351,808 shares of its common stock, in a series of sales, at an average price of $16.75 per share, in accordance with the 2018 Sales Agreement, for aggregate net proceeds of $54.1 million, after payment of cash commissions to the Sales Agent and approximately $0.2 million related to legal, accounting and other fees in connection with the sales. As of September 30, 2019, approximately $14.0 million in shares of common stock remain eligible for sale under the 2018 Sales Agreement.

On August 23, 2019, the Company filed a Registration Statement on Form S-3, as amended (the “2019 Shelf”) with the SEC in relation to the registration of common stock, preferred stock, warrants and units of any combination thereof. The Company also simultaneously entered into an Open Market Sale Agreement with the Sales Agent, to provide for the offering, issuance and sale by the Company of up to an aggregate amount of $150.0 million of its common stock from time to time in “at-the-market” offerings under the 2019 Shelf and subject to the limitations thereof.  The Company will pay to the Sales Agent cash commissions of 3.0 percent of the gross proceeds of sales of common stock under the 2019 Sales Agreement. As of September 30, 2019, the Company has incurred approximately $0.1 million related to legal fees in connection with this agreement. The Company has not issued any shares under this offering as of September 30, 2019.